Login / Signup

Neuroprotection of fullerene in improving cognitive-behavioral disruptions and neurobiochemical enzymes activities.

Davoud MalekzadehAsadollah AsadiArash AbdolmalekiGholamreza Dehghan
Published in: Nanomedicine (London, England) (2023)
Aim: Here, we report the synthesis and evaluation of fullerene C60 nanoparticles' (FC60 NPs') therapeutic efficacy in animals with aluminum-induced oxidative stress. Materials & methods: Effects of FC60 NPs on the altered activity levels of neurobiochemical enzymes and oxidative parameters in brain and liver tissues have been evaluated. Aluminum was injected for 3 weeks and from the beginning of the third week, FC60 NPs were injected for 1 week. Results: Administration of FC60 NPs showed a significant improvement in the altered activity level of the selected markers. Conclusion: Results suggest synthesized FC60 NPs as a therapeutic option for the treatment of neurodegenerative diseases.
Keyphrases
  • oxide nanoparticles
  • gene expression
  • hydrogen peroxide
  • brain injury
  • white matter
  • multiple sclerosis
  • clinical trial
  • smoking cessation
  • combination therapy
  • cerebral ischemia
  • nitric oxide
  • blood brain barrier